Breaking News Instant updates and real-time market news.

2020-04-27 16:41:06 LXFR Luxfer $14.42 / +0.67 (+4.87%) 16:41 04/27/20 04/27 16:41 04/27/20 16:41	Luxfer withdraws FY20 financial guidance Due to the economic uncertainty related to the COVID-19 pandemic, Luxfer is withdrawing its financial guidance for 2020 provided on March 5. "Given the extreme uncertain and volatile market conditions, Luxfer has decided to withdraw full year guidance. We will continue to focus on controllable business measures, such as cost reductions and cash generation," stated Mr. Maskara. "We expect the current market conditions to have a significant near-term impact on our business and have implemented various counter measures to position Luxfer for success when our markets improve. We have a strong balance sheet and also a large existing credit facility which will enable us to emerge stronger at the end of this economic downturn." The company added that, given the evolving impact of the pandemic, it is not providing any new full-year earnings guidance. It anticipates resuming practice of providing full-year earnings guidance once the degree of economic uncertainty driven by the COVID-19 pandemic subsides.	28 Apr 05 May
LXFR Luxfer $14.42 / +0.67 (+4.87%) 04/23/20 B. Riley Luxfer price target lowered to $19 from $25 at B. Riley FBR 04/03/20 Fly Intel: Top five analyst initiations 04/03/20 Roth Capital Luxfer initiated with a Buy at Roth Capital 11/19/19 B. Riley Luxfer initiated with a Buy at B. Riley FBR

2020-04-27 16:41:06

LXFR

Luxfer

$14.42 / +0.67 (+4.87%)

16:41

04/27/20

04/27

16:41

04/27/20

16:41

Luxfer withdraws FY20 financial guidance

Due to the economic uncertainty related to the COVID-19 pandemic, Luxfer is withdrawing its financial guidance for 2020 provided on March 5. "Given the extreme uncertain and volatile market conditions, Luxfer has decided to withdraw full year guidance. We will continue to focus on controllable business measures, such as cost reductions and cash generation," stated Mr. Maskara. "We expect the current market conditions to have a significant near-term impact on our business and have implemented various counter measures to position Luxfer for success when our markets improve. We have a strong balance sheet and also a large existing credit facility which will enable us to emerge stronger at the end of this economic downturn." The company added that, given the evolving impact of the pandemic, it is not providing any new full-year earnings guidance. It anticipates resuming practice of providing full-year earnings guidance once the degree of economic uncertainty driven by the COVID-19 pandemic subsides.

28
Apr
05
May

LXFR Luxfer

$14.42 / +0.67 (+4.87%)

04/23/20 B. Riley: Luxfer price target lowered to $19 from $25 at B. Riley FBR

04/03/20: Fly Intel: Top five analyst initiations

04/03/20 Roth Capital: Luxfer initiated with a Buy at Roth Capital

11/19/19 B. Riley: Luxfer initiated with a Buy at B. Riley FBR

TODAY'S FREE FLY STORIES

Conference/Events	Barfresh Food Group to host business news update conference call » 16:25 04/14/21 04/14 16:25 04/14/21 16:25 BRFH Barfresh Food Group / + Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events BRFH Barfresh Food Group / + 12/28/20 Barfresh Food Group says LAUSD approves Twist & Go product 16:30 Today Barfresh Food Group - BRFH
Initiation	DigitalOcean initiated with an Outperform at Oppenheimer » 16:24 04/14/21 04/14 16:24 04/14/21 16:24 DOCN DigitalOcean $43.50 / +0.14 (+0.32%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Syndicate On The Fly Events Options 24 Mar DOCN DigitalOcean $43.50 / +0.14 (+0.32%) 03/27/21 Opening Day: Vizio slides in NYSE debut after downsized IPO 05/06/21 DigitalOcean - DOCN DOCN DigitalOcean $43.50 / +0.14 (+0.32%) 08:30 Today new option listings on April 14th
Hot Stocks	Cimpress to raise $1.15B in term loan to repay existing secured debt » 16:23 04/14/21 04/14 16:23 04/14/21 16:23 CMPR Cimpress $105.00 / +0.7098 (+0.68%) Cimpress plc announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CMPR Cimpress $105.00 / +0.7098 (+0.68%) 01/27/21 Cimpress says expanding Vistaprint's TAM, reducing costs CMPR Cimpress $105.00 / +0.7098 (+0.68%) 02/03/21 Barrington Cimpress longer-term thesis intact despite profitability miss, says Barrington 01/29/21 Truist Cimpress price target raised to $124 from $112 at Truist 08/17/20 Barrington Cimpress upgraded to Outperform from Market Perform at Barrington 07/30/20 SunTrust Cimpress upgraded to Buy from Hold at SunTrust CMPR Cimpress $105.00 / +0.7098 (+0.68%) 16:22 Today Cimpress reports preliminary Q3 revenue of $579M, two estimates $526.92M 01/27/21 Cimpress reports Q2 GAAP EPS $1.22 vs. $6.81 last year
Earnings	Cimpress reports preliminary Q3 revenue of $579M, two estimates $526.92M » 16:22 04/14/21 04/14 16:22 04/14/21 16:22 CMPR Cimpress $105.00 / +0.7098 (+0.68%) Sees Q3 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CMPR Cimpress $105.00 / +0.7098 (+0.68%) 01/27/21 Cimpress says expanding Vistaprint's TAM, reducing costs CMPR Cimpress $105.00 / +0.7098 (+0.68%) 02/03/21 Barrington Cimpress longer-term thesis intact despite profitability miss, says Barrington 01/29/21 Truist Cimpress price target raised to $124 from $112 at Truist 08/17/20 Barrington Cimpress upgraded to Outperform from Market Perform at Barrington 07/30/20 SunTrust Cimpress upgraded to Buy from Hold at SunTrust CMPR Cimpress $105.00 / +0.7098 (+0.68%) 01/27/21 Cimpress reports Q2 GAAP EPS $1.22 vs. $6.81 last year
Hot Stocks	Artesian Resources raises annual dividend to $1.044 per share » 16:22 04/14/21 04/14 16:22 04/14/21 16:22 ARTNA Artesian Resources $40.39 / +0.025 (+0.06%) Artesian Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Options ARTNA Artesian Resources $40.39 / +0.025 (+0.06%) 12/22/20 Four new option listings and six option delistings on December 22nd

Hot Stocks	RenaissanceRe estimates impact of Winter Storm Uri of about $180M » 16:20 04/14/21 04/14 16:20 04/14/21 16:20 RNR RenaissanceRe $171.41 / +1.25 (+0.73%) RenaissanceRe Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events RNR RenaissanceRe $171.41 / +1.25 (+0.73%) 03/03/21 RenaissanceRe rebrands Ventures business as RenaissanceRe Capital Partners 02/05/21 RenaissanceRe raises quarterly dividend to 36c from 35c per share 01/13/21 RenaissanceRe sees net negative impact of roughly $170M on Q4 from catastrophes RNR RenaissanceRe $171.41 / +1.25 (+0.73%) 01/28/21 Wells Fargo RenaissanceRe price target lowered to $220 from $229 at Wells Fargo 01/08/21 Goldman Sachs RenaissanceRe upgraded to Conviction Buy from Neutral at Goldman Sachs 01/04/21 JPMorgan RenaissanceRe price target raised to $162 from $160 at JPMorgan 06/04/20 Wells Fargo RenaissanceRe price target raised to $229 from $190 at Wells Fargo RNR RenaissanceRe $171.41 / +1.25 (+0.73%) 01/26/21 RenaissanceRe reports Q4 operating EPS ($1.59), consensus ($1.27) 10/27/20 RenaissanceRe reports Q3 EPS 94c vs. 83c a year ago 03 Jun 04/29/21 RenaissanceRe - RNR
Options	Closing CBOE SPX and VIX Index summary for April 14th » 16:20 04/14/21 04/14 16:20 04/14/21 16:20 VIX Volatility Index S&P 500 Options / + The CBOE Volatility Index… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Options VIX Volatility Index S&P 500 Options / + 09:18 Today Overnight activity included 632 trades in SPX and 31 trades in VIX 04/13/21 Closing CBOE SPX and VIX Index summary for April 13th 04/13/21 Overnight activity included 960 trades in SPX and 47 trades in VIX 04/12/21 Closing CBOE SPX and VIX Index summary for April 12th
Periodicals	Las Vegas Sands running ads to campaign for Texas casinos, Texas Tribune reports » 16:19 04/14/21 04/14 16:19 04/14/21 16:19 LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) Las Vegas Sands is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) 04/01/21 Macau reports March casino revenue up 58.0% to 8.31B patacas 03/25/21 Nevada reports statewide February gaming win down 26% to $772.41M 03/18/21 Connecticut Governor Lamont, tribes reach gambling agreement 03/03/21 VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) 04/07/21 Truist Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud' 04/06/21 Credit Suisse Reports, contacts point to sports betting momentum in NY, Credit Suisse says 03/29/21 Deutsche Bank New York may be 'kicking the can' on sports betting, says Deutsche 03/18/21 JPMorgan Micro-betting market in U.S. 'could be substantial,' says JPMorgan LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) 01/27/21 Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c) 01/27/21 Notable companies reporting after market close 10/21/20 Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c) 10/21/20 Notable companies reporting after market close LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 04/01/21 Macau gaming revenue continues streak, gaining 58% year-over-year in March 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 05/13/21 Las Vegas Sands Corp. LVS Las Vegas Sands $61.30 / +0.3 (+0.49%) 02/11/21 Las Vegas Sands put volume heavy and directionally bearish 02/05/21 Early notable gainers among liquid option names on February 5th 01/27/21 Las Vegas Sands call volume above normal and directionally bullish 11/02/20 Unusually active option classes on open November 2nd
Hot Stocks	Alliance Data names Perry Beberman as CFO, succeeding Tim King » 16:19 04/14/21 04/14 16:19 04/14/21 16:19 ADS Alliance Data $107.49 / +1.9 (+1.80%) , BAC Bank of America $39.90 / +0.59 (+1.50%) Alliance Data Systems… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ADS BAC ADS Alliance Data $107.49 / +1.9 (+1.80%) 03/15/21 Alliance Data reports February net charge offs 5.2% vs. 4.6% last month 02/25/21 Alliance Data partners with Victoria's Secret on private label credit card 02/16/21 Alliance Data reports January net charge offs 4.6% vs. 8.7% last month 02/02/21 Alliance Data launches private label credit card program for Famous Footwear BAC Bank of America $39.90 / +0.59 (+1.50%) 04/06/21 MoneyGram appoints Hilary Jackson as COO 04/02/21 Bank of America acquires health care payment company Axia 03/25/21 Fed plans to end temporary restrictions on bank dividends, share repurchases 03/19/21 Fed says supplementary leverage ratio to expire as scheduled on March 31 ADS BAC ADS Alliance Data $107.49 / +1.9 (+1.80%) 04/08/21 Evercore ISI Alliance Data initiated with an In Line at Evercore ISI 03/31/21 Argus Alliance Data price target raised to $130 from $95 at Argus 03/26/21 Morgan Stanley Alliance Data price target raised to $150 from $105 at Morgan Stanley 03/18/21 Oppenheimer Alliance Data price target raised to $130 from $85 at Oppenheimer BAC Bank of America $39.90 / +0.59 (+1.50%) 04/09/21 Jefferies Bank of America price target raised to $41 from $33 at Jefferies 04/07/21 Barclays Bank of America price target raised to $45 from $40 at Barclays 04/05/21 Cowen Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen 04/01/21 Deutsche Bank Bank of America price target raised to $44 from $35 at Deutsche Bank ADS BAC ADS Alliance Data $107.49 / +1.9 (+1.80%) 01/28/21 Alliance Data reports Q4 core EPS $3.31, consensus $2.41 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/29/20 Alliance Data reports Q3 EPS $2.79, consensus $2.25 BAC Bank of America $39.90 / +0.59 (+1.50%) 14:20 Today Fly Intel: What to watch in next round of big bank earnings reports 14:00 Today Notable companies reporting before tomorrow's open 01/19/21 Bank of America reports Q4 EPS 59c, consensus 55c 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports BAC BAC Bank of America $39.90 / +0.59 (+1.50%) 02/26/21 BofA, JPMorgan give U.S. employees PTO for COVID-19 vaccinations, Reuters says 02/20/21 Bank stocks still have room to run, Barron's says 02/15/21 Citi, Bank of America cut CEO pay, WSJ reports 01/22/21 Bank of America to pay bonuses for work during the pandemic, CNBC reports ADS BAC ADS Alliance Data $107.49 / +1.9 (+1.80%) 10/29/20 Fly Intel: Wall Street's top stories for Thursday 10/29/20 Fly Intel: Wall Street's top stories at midday 10/29/20 Fly Intel: Pre-market Movers BAC Bank of America $39.90 / +0.59 (+1.50%) 03/19/21 Fly Intel: Wall Street's top stories for Friday 03/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 04/15/21 Bank of America - BAC 04/20/21 Bank of America Corporation ADS BAC ADS Alliance Data $107.49 / +1.9 (+1.80%) 12/23/20 Early notable gainers among liquid option names on December 23rd 12/01/20 Early notable gainers among liquid option names on December 1st 11/13/20 Early notable gainers among liquid option names on November 13th 10/29/20 Early notable gainers among liquid option names on October 29th BAC Bank of America $39.90 / +0.59 (+1.50%) 04/05/21 Unusual call flow in option market yesterday 04/01/21 Size call spread adjustment in Bank of America 03/26/21 Unusually active option classes on open March 26th 03/19/21 Unusually active option classes on open March 19th
Earnings	KLX Energy reports Q4 EPS ($3.69), one estimate ($3.14) » 16:19 04/14/21 04/14 16:19 04/14/21 16:19 KLXE KLX Energy $14.52 / +0.345 (+2.43%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Events Options 04/15/21 KLX Energy - KLXE KLXE KLX Energy $14.52 / +0.345 (+2.43%) 01/19/21 Nine new option listings and thirteen option delistings on January 19th

Hot Stocks	Tegna raises quarterly divend by 36% to 9.5c per share » 16:18 04/14/21 04/14 16:18 04/14/21 16:18 TGNA Tegna $20.43 / +0.115 (+0.57%) Dividend is payable on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGNA Tegna $20.43 / +0.115 (+0.57%) 03/29/21 Tegna raises quarterly dividend by 36% to 9.5c per share 03/18/21 Tegna shareholder Standard General issues letter to board 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/10/21 Entercom announces content agreement with Tegna podcast network TGNA Tegna $20.43 / +0.115 (+0.57%) 01/08/21 Barrington Tegna price target raised to $20 from $18 at Barrington 12/16/20 Huber Research Tegna downgraded to Underweight from Overweight at Huber Research 08/11/20 Wells Fargo Tegna upgraded to Overweight from Equal Weight at Wells Fargo 04/16/20 Wells Fargo Tegna price target lowered to $11 from $18 at Wells Fargo TGNA Tegna $20.43 / +0.115 (+0.57%) 16:18 Today Tegna sees Q2 revenue up mid to high twenties percent 16:17 Today Tegna reports preliminary Q1 EPS 52c, consensus 46c 03/01/21 Tegna reports Q4 EPS $1.16, consensus $1.12 01/06/21 Tegna sees FY20 revenue $2.93B-$2.94B, consensus $2.91B TGNA Tegna $20.43 / +0.115 (+0.57%) 03/09/21 Tegna board nominee Adonis Hoffman withdraws, WSJ reports 03/05/21 Standard General invigorates push for Tegna board seats, Bloomberg reports TGNA Tegna $20.43 / +0.115 (+0.57%) 10/15/20 Fly Intel: Pre-market Movers 05/10/21 Tegna - TGNA TGNA Tegna $20.43 / +0.115 (+0.57%) 01/21/21 Early notable gainers among liquid option names on January 21st 10/15/20 Early notable gainers among liquid option names on October 15th
Earnings	Tegna sees Q2 revenue up mid to high twenties percent » 16:18 04/14/21 04/14 16:18 04/14/21 16:18 TGNA Tegna $20.43 / +0.115 (+0.57%) Sees FY21 subscription… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGNA Tegna $20.43 / +0.115 (+0.57%) 03/29/21 Tegna raises quarterly dividend by 36% to 9.5c per share 03/18/21 Tegna shareholder Standard General issues letter to board 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/10/21 Entercom announces content agreement with Tegna podcast network TGNA Tegna $20.43 / +0.115 (+0.57%) 01/08/21 Barrington Tegna price target raised to $20 from $18 at Barrington 12/16/20 Huber Research Tegna downgraded to Underweight from Overweight at Huber Research 08/11/20 Wells Fargo Tegna upgraded to Overweight from Equal Weight at Wells Fargo 04/16/20 Wells Fargo Tegna price target lowered to $11 from $18 at Wells Fargo TGNA Tegna $20.43 / +0.115 (+0.57%) 16:17 Today Tegna reports preliminary Q1 EPS 52c, consensus 46c 03/01/21 Tegna reports Q4 EPS $1.16, consensus $1.12 01/06/21 Tegna sees FY20 revenue $2.93B-$2.94B, consensus $2.91B 01/06/21 Tegna reports preliminary Q4 revenue $932M-$937M, consensus $904.12M TGNA Tegna $20.43 / +0.115 (+0.57%) 03/09/21 Tegna board nominee Adonis Hoffman withdraws, WSJ reports 03/05/21 Standard General invigorates push for Tegna board seats, Bloomberg reports TGNA Tegna $20.43 / +0.115 (+0.57%) 10/15/20 Fly Intel: Pre-market Movers 05/10/21 Tegna - TGNA TGNA Tegna $20.43 / +0.115 (+0.57%) 01/21/21 Early notable gainers among liquid option names on January 21st 10/15/20 Early notable gainers among liquid option names on October 15th
Hot Stocks	TreeHouse COO Shay Braun to leave effective April 30 » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 THS TreeHouse $51.22 / -0.24 (-0.47%) TreeHouse Foods announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events THS TreeHouse $51.22 / -0.24 (-0.47%) 03/31/21 TreeHouse announces commercial organization leadership changes 03/22/21 TreeHouse appoints Ann Sardini as board chair 03/02/21 TreeHouse announces pact with JANA Partners to appoint board members 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 THS TreeHouse $51.22 / -0.24 (-0.47%) 02/12/21 Truist TreeHouse downgraded to Hold from Buy at Truist 02/12/21 Truist TreeHouse downgraded to Hold from Buy at Truist 02/12/21 BofA TreeHouse downgraded to Neutral from Buy at BofA 02/12/21 BofA TreeHouse downgraded to Neutral from Buy at BofA THS TreeHouse $51.22 / -0.24 (-0.47%) 02/11/21 TreeHouse sees 2021 adjusted EPS $2.80-$3.20, consensus $3.02 02/11/21 TreeHouse reports Q4 adjusted EPS $1.07, consensus $1.06 02/10/21 Notable companies reporting before tomorrow's open 02/10/21 Notable companies reporting before tomorrow's open THS TreeHouse $51.22 / -0.24 (-0.47%) 03/30/21 Sector advisors speculate TreeHouse could draw interest, Dealreporter says 02/10/21 Jana pushing TreeHouse to explore potential sale, Bloomberg reports THS TreeHouse $51.22 / -0.24 (-0.47%) 02/12/21 Initiation of 'disrupter' Inovio among today's top calls on Wall Street 05/06/21 TreeHouse - THS 04/29/21 TreeHouse Foods, Inc.
Hot Stocks	Bristol-Myers receives EC approval for opdivo-cabometyx combination » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 BMY Bristol-Myers $63.82 / +0.22 (+0.35%) Bristol Myers Squibb… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/11/21 Bristol-Myers announces results from CheckMate -816 study 04/08/21 Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial 04/01/21 Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers 03/30/21 Huyabio International enters clinical collaboration agreement with Bristol-Myers BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish
Hot Stocks	Costco increases quarterly cash dividend to 79c per share » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 COST Costco $363.11 / -2.14 (-0.59%) Costco announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options COST Costco $363.11 / -2.14 (-0.59%) 04/07/21 Costco March SSS ex-impac from gas F/X up 11.1% 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% COST Costco $363.11 / -2.14 (-0.59%) 04/08/21 DA Davidson Costco March sales data 'very strong', says DA Davidson 04/08/21 Oppenheimer Costco price target raised to $400 from $370 at Oppenheimer 04/08/21 Wells Fargo Costco price target raised to $400 from $370 at Wells Fargo 04/08/21 Stifel Costco price target raised to $385 from $370 at Stifel COST Costco $363.11 / -2.14 (-0.59%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $363.11 / -2.14 (-0.59%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $363.11 / -2.14 (-0.59%) 03/11/21 Tesla initiation, GE downgrade among today's top calls on Wall Street 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Fly Intel: Pre-market Movers 05/27/21 Costco - COST COST Costco $363.11 / -2.14 (-0.59%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th

Conference/Events	Jazz Pharmaceuticals to host conference call » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 04/12/21 Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav 04/01/21 Lava Therapeutics appoints Karen Wilson to board of directors 03/30/21 Jazz announces FDA approved revised label for Vyxeos 02/16/21 Jazz completes rolling submission for sNDA to FDA for Xywav oral solution JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 08:12 Today Stifel Jazz Pharmaceuticals price target raised to $202 from $195 at Stifel 04/06/21 RBC Capital Jazz Pharmaceuticals transferred with an Outperform at RBC Capital 04/01/21 Morgan Stanley Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley 03/01/21 UBS Jazz Pharmaceuticals price target raised to $228 from $174 at UBS JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 02/23/21 Jazz Pharmaceuticals sees FY21 adjusted EPS $15.65-$16.85, consensus $16.78 02/23/21 Jazz Pharmaceuticals reports Q4 EPS $4.00, consensus $4.20 02/16/21 GW Pharmaceuticals reports Q4 EPS (8c), consensus (60c) 11/02/20 Jazz Pharma narrows FY20 non-GAAP EPS view to $12.20-$13.00 from $11.90-$13.00 JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 04/05/21 'Failure is the new winning' for Jazz Pharmaceuticals, FFJ says JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 04/20/21 Jazz Pharmaceuticals - JAZZ 08/12/21 PDFUA Date for Xywav
Earnings	Tegna reports preliminary Q1 EPS 52c, consensus 46c » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 TGNA Tegna $20.43 / +0.115 (+0.57%) Reports Q1 preliminary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGNA Tegna $20.43 / +0.115 (+0.57%) 03/29/21 Tegna raises quarterly dividend by 36% to 9.5c per share 03/18/21 Tegna shareholder Standard General issues letter to board 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/10/21 Entercom announces content agreement with Tegna podcast network TGNA Tegna $20.43 / +0.115 (+0.57%) 01/08/21 Barrington Tegna price target raised to $20 from $18 at Barrington 12/16/20 Huber Research Tegna downgraded to Underweight from Overweight at Huber Research 08/11/20 Wells Fargo Tegna upgraded to Overweight from Equal Weight at Wells Fargo 04/16/20 Wells Fargo Tegna price target lowered to $11 from $18 at Wells Fargo TGNA Tegna $20.43 / +0.115 (+0.57%) 03/01/21 Tegna reports Q4 EPS $1.16, consensus $1.12 01/06/21 Tegna sees FY20 revenue $2.93B-$2.94B, consensus $2.91B 01/06/21 Tegna reports preliminary Q4 revenue $932M-$937M, consensus $904.12M 11/09/20 Tegna reports Q3 EPS 59c, consensus 49c TGNA Tegna $20.43 / +0.115 (+0.57%) 03/09/21 Tegna board nominee Adonis Hoffman withdraws, WSJ reports 03/05/21 Standard General invigorates push for Tegna board seats, Bloomberg reports TGNA Tegna $20.43 / +0.115 (+0.57%) 10/15/20 Fly Intel: Pre-market Movers 05/10/21 Tegna - TGNA TGNA Tegna $20.43 / +0.115 (+0.57%) 01/21/21 Early notable gainers among liquid option names on January 21st 10/15/20 Early notable gainers among liquid option names on October 15th
Technical Analysis	NASDAQ market internals summary » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 $NSD NASDAQ Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary
Hot Stocks	Axis Capital sees Q1 pre-tax net loss estimates for catastrophes of $105M-$115M » 16:16 04/14/21 04/14 16:16 04/14/21 16:16 AXS Axis Capital $52.70 / +0.56 (+1.07%) Axis Capital announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AXS Axis Capital $52.70 / +0.56 (+1.07%) 01/19/21 Axis Capital announces preliminary Q4 claims estimate of $195M-$205M 12/03/20 Axis Capital raises quarterly dividend 2.4% to 42c per share AXS Axis Capital $52.70 / +0.56 (+1.07%) 03/29/21 Deutsche Bank Axis Capital price target raised to $52 from $46 at Deutsche Bank 01/07/21 BofA Axis Capital downgraded to Underperform from Neutral at BofA 11/27/20 MKM Partners Axis Capital price target raised to $65 from $55 at MKM Partners 11/03/20 Deutsche Bank Axis Capital price target raised to $44 from $42 at Deutsche Bank AXS Axis Capital $52.70 / +0.56 (+1.07%) 01/27/21 Axis Capital reports Q4 operating EPS (20c), consensus (40c) 10/28/20 Axis Capital reports Q3 operating EPS (77c), consensus (48c) 04/29/21 Axis Capital - AXS
Technical Analysis	NYSE market internals summary » 16:16 04/14/21 04/14 16:16 04/14/21 16:16 $NYE NYSE Market Internals / + Volume was average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary

Hot Stocks	Regenxbio says first patient dosed in Cohort 3 of Phase I/II trial of RGX-121 » 16:15 04/14/21 04/14 16:15 04/14/21 16:15 RGNX Regenxbio $35.35 / +0.82 (+2.37%) Regenxbio announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events RGNX Regenxbio $35.35 / +0.82 (+2.37%) 03/01/21 Regenxbio expects cash to fund operations into second half of 2023 02/16/21 Regenxbio announces additional interim Phase I/IIa data of RGX-314 02/08/21 Regenxbio says interim data shows RGX-121 continues to be well-tolerated 01/05/21 Regenxbio: Pivotal program for RGX-314 for treatment of wet AMD now active RGNX Regenxbio $35.35 / +0.82 (+2.37%) 04/05/21 Morgan Stanley Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley 02/09/21 Morgan Stanley Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley 01/20/21 RBC Capital Regenxbio price target raised to $50 from $42 at RBC Capital 01/06/21 Chardan Regenxbio named top 2021 pick with $100 target at Chardan RGNX Regenxbio $35.35 / +0.82 (+2.37%) 03/01/21 Regenxbio reports Q4 EPS ($1.24), consensus (43c) 08 Jan RGNX Regenxbio $35.35 / +0.82 (+2.37%) 01/06/21 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021
Hot Stocks	Rise Education reports new and total enrollment at end of Q1 » 16:14 04/14/21 04/14 16:14 04/14/21 16:14 REDU Rise Education $3.45 / +0.04 (+1.17%) Rise Education announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings REDU Rise Education $3.45 / +0.04 (+1.17%) 11/23/20 Rise Education CFO Jiandong Lu resigns, Warren Wang to succeed REDU Rise Education $3.45 / +0.04 (+1.17%) 05/18/20 Credit Suisse Rise Education upgraded to Outperform from Neutral at Credit Suisse REDU Rise Education $3.45 / +0.04 (+1.17%) 11/12/20 Rise Education sees Q4 revenue of RMB 355M to RMB 365M 11/12/20 Rise Education reports Q3 non-GAAP EPS 63c vs. 85c a year ago
Hot Stocks	Dell Technologies jumps 8% to $100.40 after planned VMware spin-off » 16:11 04/14/21 04/14 16:11 04/14/21 16:11 DELL Dell Technologies $92.72 / +0.18 (+0.19%) , VMW VMware $155.48 / +1.24 (+0.80%) VMware is up 1.5% to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 16:08 Today Dell Technologies announces planned VMware spin-off 16:05 Today Dell Technologies announces planned VMware spin-off 02/16/21 Elliott buys Evergy, exits eBay in Q4 11/24/20 Dell Technologies reports Q3 Infrastructure Solutions Group revenue $8B VMW VMware $155.48 / +1.24 (+0.80%) 16:08 Today Dell Technologies announces planned VMware spin-off 16:05 Today Dell Technologies announces planned VMware spin-off 04/05/21 VMware COO sells 30.8K shares of common stock 02/10/21 Accenture and VMware extend relationship with dedicated business group DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 04/13/21 Morgan Stanley IT hardware analyst to hold analyst/industry conference call 04/08/21 Morgan Stanley Dell Technologies price target raised to $107 from $98 at Morgan Stanley 04/07/21 Deutsche Bank Dell Technologies price target raised to $100 from $94 at Deutsche Bank 02/26/21 JPMorgan Dell Technologies price target raised to $98 from $90 at JPMorgan VMW VMware $155.48 / +1.24 (+0.80%) 04/08/21 BofA VMware reinstated with a Neutral at BofA 04/08/21 BofA VMware reinstated with a Neutral at BofA 03/15/21 Credit Suisse VMware assumed with a Neutral at Credit Suisse 03/03/21 Citi VMware assumed with a Buy at Citi DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 02/25/21 Dell Technologies reports Q4 adjusted EPS $2.70, consensus $2.14 02/25/21 Notable companies reporting after market close 11/24/20 Dell Technologies sees Q4 revenue up 3%-4% sequentially, consensus $23.09B 11/24/20 Dell Technologies reports Q3 adjusted EPS $2.03, consensus $1.40 VMW VMware $155.48 / +1.24 (+0.80%) 02/25/21 VMware sees FY22 EPS $6.68, consensus $6.95 02/25/21 VMware sees Q1 EPS $1.49, consensus $1.48 02/25/21 VMware reports Q4 EPS $2.21, consensus $2.05 02/25/21 Notable companies reporting after market close DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 03/15/21 Alienware ends Riot esports sponsorship amid harassment claims, Dot Esports says 02/04/21 Boeing to outsource IT work to Dell, slash 600 jobs, AP reports VMW VMware $155.48 / +1.24 (+0.80%) 01/13/21 Intel CEO Swan stepping down, WMware CEO Gelsinger to replace him, CNBC says 01/13/21 Intel CEO Swan to be replaced by VMware's Pat Gelsinger, CNBC reports 01/13/21 Intel CEO Bob Swan to step down, to be replaced by Gelsinger, CNBC reports 12/21/20 Tech giants join Facebook's legal battle against Israel's NSO, Reuters says DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 03/16/21 Game On: NPD says February game spending jumped 35% y/y 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/25/20 Fly Intel: Wall Street's top stories for Wednesday VMW VMware $155.48 / +1.24 (+0.80%) 04/08/21 Adobe coverage reinstatement, Carvana initiation among top calls on Wall Street 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 02/25/21 Fly Intel: After-Hours Movers 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 05/27/21 Dell Technologies - DELL DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 10/26/20 Dell Technologies put volume heavy and directionally bearish VMW VMware $155.48 / +1.24 (+0.80%) 12/18/20 VMware put volume heavy and directionally bearish 10/27/20 Largest borrow rate increases among liquid names 10/26/20 VMware put volume heavy and directionally bearish
Hot Stocks	InspireMD announces 1-for-15 reverse stock split » 16:10 04/14/21 04/14 16:10 04/14/21 16:10 NSPR InspireMD / + InspireMD announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate NSPR InspireMD / + 03/22/21 InspireMD CEO urges stockholders to support plans to list on Nasdaq 02/24/21 InspireMD engages Hart Clinical Consultants for CGuard stent system trial 02/03/21 InspireMD secures partner for intended distribution of CGuard EPS in China 11/03/20 InspireMD appoints Andrea Tommasoli as SVP, global sales and marketing NSPR InspireMD / + 10/16/20 Alliance Global Partners InspireMD initiated with a Buy at Alliance Global Partners NSPR InspireMD / + 11/09/20 InspireMD reports Q3 EPS (6c), consensus (18c) 04 Feb
Initiation	Elanco initiated with a Buy at Stifel » 16:09 04/14/21 04/14 16:09 04/14/21 16:09 ELAN Elanco $29.54 / +0.175 (+0.60%) Stifel analyst Jonathan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ELAN Elanco $29.54 / +0.175 (+0.60%) 03/19/21 Elanco reiterates it 'stands behind the safety data of Seresto' 03/03/21 Elanco off lows, turns positive after WSJ report of Starboard board nominations 02/25/21 Kindred submits efficacy data to support prophylactic indication for KIND-030 02/25/21 Apria names Michael-Bryant Hicks as EVP, general counsel ELAN Elanco $29.54 / +0.175 (+0.60%) 03/22/21 Fly Intel: Top five analyst downgrades 03/22/21 Gabelli Elanco downgraded to Hold from Buy at Gabelli 03/08/21 Citi Elanco price target raised to $39 from $35 at Citi 02/26/21 Barclays Judge allows challenge to Elanco's Experior, says Barclays ELAN Elanco $29.54 / +0.175 (+0.60%) 02/24/21 Elanco raises FY21 adjusted EPS view to 90c-$1.00 from 83c-95c, consensus 91c 02/24/21 Elanco sees Q1 adjusted EPS 20c-25, consensus 22c 02/24/21 Elanco reports Q4 adjusted EPS 12c, consensus 9c 02/23/21 Notable companies reporting before tomorrow's open 01 Dec ELAN Elanco $29.54 / +0.175 (+0.60%) 03/29/21 Starboard withdrew Elanco board nominations earlier this month, Reuters reports 03/29/21 Starboard withdrew Elanco board nominations, Reuters reports 03/03/21 Starboard takes Elanco stake, nominates three to board, WSJ reports 03/03/21 Activist Starboard takes stake in Elanco, makes board nominations, WSJ says ELAN Elanco $29.54 / +0.175 (+0.60%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Pre-market Movers 11/09/20 Biogen downgrade, Fisker initiation among today's top calls on Wall Street 11/06/20 Fly Intel: Pre-market Movers 05/07/21 Elanco - ELAN 05/19/21 Elanco Animal Health, Inc. ELAN Elanco $29.54 / +0.175 (+0.60%) 12/14/20 Elanco Animal Health call volume above normal and directionally bullish 11/27/20 Elanco Animal Health put volume heavy and directionally bearish

Events

Earnings calls, analyst events, roadshows and more

BRFH
Today at 16:30

Barfresh Food Group - BRFH Conference Calls
Today at 18:05

Fed Reserve Bank President Participates in Virtual Event Government Event

Virtual Event
GHG
Today at 21:00

GreenTree Hospitality - GHG Conference Calls
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
VERI
Tomorrow at 00:00

Veritone - VERI Conference Calls
COO
Tomorrow at 00:00

Cooper Companies - COO Conference Calls
VNRX
Tomorrow at 00:00

VolitionRx - VNRX Conference Calls
Tomorrow at 00:00

Annual Clinical Genetics Virtual Meeting of ACMG Conferences

Virtual Meeting
HD ...
Tomorrow at 00:00

7th Annual Virtual Retail Round-Up Conferences

Virtual Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: SBHS $10.94 45M Shares
Fri	No deals

View All Syndicate Announcements »

Luxfer withdraws FY20 financial guidance

TODAY'S FREE FLY STORIES

Get Full Fly Access